Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 16 EP applications Rebecca Marie Tollervey has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11849944

MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF

IPC classification:
C12N 15/44, A61K 39/145
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12835033

RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS

IPC classification:
A61K 39/155
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Agent:
Cooley (UK) LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12853168

TREATMENT OF B CELL LYMPHOMAS

IPC classification:
A61P 35/00, A61K 9/16, A61K 31/7088, A61K 31/7105, A61K 38/16, A61K 38/17, A61K 48/00
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14170551

Methods for genetic analysis

IPC classification:
C12Q 1/68
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13791616

CARRIERS FOR IMPROVED DRUG DELIVERY

IPC classification:
C08F 12/28, A01N 25/00, A01N 43/42
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13807804

PURIFICATION OF VIRUS LIKE PARTICLES

IPC classification:
C12N 7/02, A61K 39/125
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13711221

EFFICIENT COMPARISON OF POLYNUCLEOTIDE SEQUENCES

IPC classification:
G06F 19/22
Applicant:
Illumina, Inc.
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13165622

Cell sheet having good dimensional stability, method for production thereof, and cell culture carrier for use in the method

IPC classification:
C12N 5/00
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12198722

Methods useful in nucleic acid sequencing protocols

IPC classification:
C12N 15/11, C12Q 1/68
Applicant:
Illumina, Inc.
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10856376

ELECTRIC CURTAIN-CLOSING DEVICE AND CURTAIN-CLOSING METHOD USING SAME

IPC classification:
A47H 5/02
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16160404

TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE

IPC classification:
G01N 33/68, G01N 33/92
Applicant:
The Cleveland Clinic Foundation
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15857562

HAND, FOOT, AND MOUTH VACCINES AND METHODS OF MANUFACTURE AND USE THEREOF

IPC classification:
C12N 15/41
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP15852241

THERAPEUTIC VITAMIN D CONJUGATES

IPC classification:
A61K 47/60, A61K 38/22
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP16749976

METHODS FOR PRODUCING VIRUS FOR VACCINE PRODUCTION

IPC classification:
C12N 7/00
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP17174600

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

IPC classification:
A61P 35/00, A61K 47/68, C07K 16/28, C07K 16/30, C12N 15/13, G01N 33/574, A61K 31/537, A61K 38/05, A61K 39/00, A61K 39/395, A61K 45/06, A61K 51/10
Applicant:
Genentech, Inc.
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
The application has been published
EP16777311

ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
C12N 5/02, A61K 31/7088, A61K 38/12, A61K 39/395
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature